[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FI925617A0 - Guanidinalkyl-1,1-bisfosfonsyraderivat, foerfarande foer framstaellning av dessa och anvaendning av dessa - Google Patents

Guanidinalkyl-1,1-bisfosfonsyraderivat, foerfarande foer framstaellning av dessa och anvaendning av dessa

Info

Publication number
FI925617A0
FI925617A0 FI925617A FI925617A FI925617A0 FI 925617 A0 FI925617 A0 FI 925617A0 FI 925617 A FI925617 A FI 925617A FI 925617 A FI925617 A FI 925617A FI 925617 A0 FI925617 A0 FI 925617A0
Authority
FI
Finland
Prior art keywords
dessa
guanidinalkyl
bisphosphonyraderivat
hydrogen atom
chemical structure
Prior art date
Application number
FI925617A
Other languages
English (en)
Other versions
FI105550B (fi
FI925617A (fi
Inventor
Hans-Jochen Lang
Christoph Naumann
Denis Carniato
Anne-Marie Moura
Ryoichi Satoh
Masakazu Katoh
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of FI925617A0 publication Critical patent/FI925617A0/fi
Publication of FI925617A publication Critical patent/FI925617A/fi
Application granted granted Critical
Publication of FI105550B publication Critical patent/FI105550B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40Esters thereof
    • C07F9/4003Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4025Esters of poly(thio)phosphonic acids
    • C07F9/405Esters of poly(thio)phosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/38Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/3804Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)] not used, see subgroups
    • C07F9/3839Polyphosphonic acids
    • C07F9/3873Polyphosphonic acids containing nitrogen substituent, e.g. N.....H or N-hydrocarbon group which can be substituted by halogen or nitro(so), N.....O, N.....S, N.....C(=X)- (X =O, S), N.....N, N...C(=X)...N (X =O, S)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6503Five-membered rings
    • C07F9/6506Five-membered rings having the nitrogen atoms in positions 1 and 3
    • C07F9/65068Five-membered rings having the nitrogen atoms in positions 1 and 3 condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI925617A 1991-12-12 1992-12-10 Menetelmä terapeuttisesti käyttökelpoisten guanidiinialkyyli-1,1-bisfosfonihappojohdannaisten valmistamiseksi FI105550B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE4140908 1991-12-12
DE4140908 1991-12-12
DE4211976 1992-04-09
DE4211976 1992-04-09

Publications (3)

Publication Number Publication Date
FI925617A0 true FI925617A0 (fi) 1992-12-10
FI925617A FI925617A (fi) 1993-06-13
FI105550B FI105550B (fi) 2000-09-15

Family

ID=25910001

Family Applications (1)

Application Number Title Priority Date Filing Date
FI925617A FI105550B (fi) 1991-12-12 1992-12-10 Menetelmä terapeuttisesti käyttökelpoisten guanidiinialkyyli-1,1-bisfosfonihappojohdannaisten valmistamiseksi

Country Status (16)

Country Link
US (1) US5294608A (fi)
EP (1) EP0546548B1 (fi)
JP (1) JP3377234B2 (fi)
KR (1) KR100269544B1 (fi)
AT (1) ATE152453T1 (fi)
AU (1) AU657018B2 (fi)
BR (1) BR9204984A (fi)
CA (1) CA2085171C (fi)
DE (1) DE59208426D1 (fi)
DK (1) DK0546548T3 (fi)
ES (1) ES2101012T3 (fi)
FI (1) FI105550B (fi)
MX (1) MX9207215A (fi)
NZ (1) NZ245414A (fi)
RU (1) RU2124519C1 (fi)
TW (1) TW222637B (fi)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8922026D0 (en) * 1989-09-29 1989-11-15 Pharma Mar Sa Novel anti-viral and cytotoxic agent
US20030148933A1 (en) * 1990-10-01 2003-08-07 Pharma Mar S.A. Derivatives of dehydrodidemnin B
DE4223940A1 (de) * 1992-07-21 1994-01-27 Boehringer Mannheim Gmbh Neue acyclische Amidingruppen-haltige Diphosphonsäurederivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
ATE176476T1 (de) * 1992-12-02 1999-02-15 Hoechst Ag Guanidinalkyl-1, 1-bisphosphonsäurederivate, verfahren zu ihrer herstellung und ihre verwendung
JPH06298779A (ja) * 1993-04-15 1994-10-25 Hoechst Japan Ltd ヘテロ環イミノビスメチレンビスホスホン酸誘導体
US5854227A (en) * 1994-03-04 1998-12-29 Hartmann; John F. Therapeutic derivatives of diphosphonates
DE19546736A1 (de) * 1995-12-14 1997-06-19 Hoechst Ag Substituierte Chromanylsulfonyl(thio)harnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung pharmazeutischer Präparate
ZA981936B (en) * 1997-03-07 1999-09-06 Metabasis Therapeutics Inc Novel benzimidazole inhibitors of fructose 1,6-bisphosphatase.
WO1998039344A1 (en) 1997-03-07 1998-09-11 Metabasis Therapeutics, Inc. Novel purine inhibitors of fructose-1,6-bisphosphatase
IT1303672B1 (it) 1998-07-28 2001-02-23 Nicox Sa Sali nitrati di farmaci attivi nei disordini ossei
JP2003519183A (ja) * 2000-01-04 2003-06-17 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 心臓および動脈の石灰化を抑制する低用量ビスホスホネートの使用
US7358361B2 (en) * 2004-10-08 2008-04-15 The Board Of Trustees Of The University Of Illinois Biophosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases
WO2007109585A2 (en) * 2006-03-17 2007-09-27 The Board Of Trustees Of The University Of Illinois Bisphosphonate compounds and methods
US8012949B2 (en) * 2004-10-08 2011-09-06 The Board Of Trustees Of The University Of Illinois Bisphosphonate compounds and methods with enhanced potency for multiple targets including FPPS, GGPPS, and DPPS
US7457149B2 (en) 2006-05-05 2008-11-25 Macronix International Co., Ltd. Methods and apparatus for thermally assisted programming of a magnetic memory device
CN101679466A (zh) * 2007-04-12 2010-03-24 伊利诺伊大学评议会 对包括fpps、ggpps和dpps在内的多靶点效力提高的二膦酸盐化合物及方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3225469A1 (de) * 1982-07-05 1984-01-05 Schering AG, 1000 Berlin und 4709 Bergkamen Diphosphonsaeure-derivate und diese enthaltende pharmazeutische praeparate
IL77243A (en) * 1984-12-21 1996-11-14 Procter & Gamble Pharmaceutical compositions containing geminal diphosphonic acid compounds and certain such novel compounds
EP0243173B1 (en) * 1986-04-24 1991-06-26 Fujisawa Pharmaceutical Co., Ltd. New diphosphonic acid compounds, processes for the preparation thereof and pharmaceutical composition comprising the same
EP0282309A3 (en) * 1987-03-11 1990-03-14 Yamanouchi Pharmaceutical Co. Ltd. Azole-aminomethylene bisphosphonic acid derivatives
IL86951A (en) * 1987-07-06 1996-07-23 Procter & Gamble Pharma Methylene phosphonoalkylphosphinates and pharmaceutical preparations containing them
US4990503A (en) * 1988-08-12 1991-02-05 Yamanouchi Pharmaceutical Co., Ltd. Heterocyclic bisphosphonic acid derivatives

Also Published As

Publication number Publication date
FI105550B (fi) 2000-09-15
TW222637B (fi) 1994-04-21
AU657018B2 (en) 1995-02-23
ES2101012T3 (es) 1997-07-01
US5294608A (en) 1994-03-15
JP3377234B2 (ja) 2003-02-17
BR9204984A (pt) 1993-06-15
CA2085171A1 (en) 1993-06-13
RU2124519C1 (ru) 1999-01-10
EP0546548A1 (de) 1993-06-16
ATE152453T1 (de) 1997-05-15
MX9207215A (es) 1993-06-01
FI925617A (fi) 1993-06-13
CA2085171C (en) 2003-12-02
NZ245414A (en) 1995-04-27
AU3017392A (en) 1993-06-17
KR100269544B1 (ko) 2000-10-16
EP0546548B1 (de) 1997-05-02
DE59208426D1 (de) 1997-06-05
JPH05271260A (ja) 1993-10-19
DK0546548T3 (da) 1997-10-13

Similar Documents

Publication Publication Date Title
FI925617A0 (fi) Guanidinalkyl-1,1-bisfosfonsyraderivat, foerfarande foer framstaellning av dessa och anvaendning av dessa
HUP9701596A2 (hu) 2,4-Diamino-1,3,5-triazin-származékok, eljárás előállításukra, alkalmazásuk gyógyszerkészítmények előállítására és az ezeket tartalmazó gyógyszerkészítmények
DE69513383D1 (de) Substituierte 3-arylidinene-7-azaoxindol verbindungen und verfahren zu ihrer herstellung
DK139287A (da) Tertiaere hydroxyalkylxanthiner, deres fremstilling og anvendelse som laegemidler
FI913478A0 (fi) Diazinderivat.
FI912998A (fi) Foerfarande foer framstaellning av aralifatiskt n-substituerade aminoalkanfosfinsyror.
HUP9700992A2 (hu) 3-(Piperid-4-il)-1,2-benzizoxazol- és 3-(piperazin-4-il)-1,2-benzizoxazol-származékok, eljárás előállításukra, valamint ezeket tartalmazó gyógyászati készítmények
HU9402302D0 (en) New benzocycloheptienes, and benzoxepines, pharmaceutical compositions containing them and process for producing them
ES423466A1 (es) Procedimiento para la preparacion de nuevos 1-ariloxi-2-hi- droxi-3-alquinilaminopropanos.
ES448475A1 (es) Procedimiento de preparacion de derivados triyodados del benceno.
NO158578C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3,1-benzoksazin-2-on-derivater.
GB961037A (en) Pyrazolones and processes for their preparation
DK0498718T3 (da) Anvendelse af 4-(3-trifluormethylphenyl)-1,2,3,6-tetrahydropyridinderivater som indfangere af frie radikaler
ES467069A1 (es) Un procedimiento para la preparacion de nuevos derivados de 1-3-bencenodimetanol
ES442119A1 (es) Procedimiento para la preparacion de compuestos tetracicli- cos sustituidos en el grupo amino.
MY113584A (en) Prokinetic oxadiazoles
ES8303377A1 (es) "procedimiento para la preparacion de nuevas 2(3h)-benzotiazolonas".
NO166321C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyridinforbindelser.
ES471895A1 (es) Procedimiento para preparar derivados de benzamidina
GB868353A (en) Phenyl piperazine derivatives for therapeutic use and processes for the production of such derivatives
ATE35538T1 (de) (substituierte phenyl)-5-oxo-2pyrrolidinpropions|uren, verfahren zur herstellung dieser verbindungen und diese verbindungen enthaltende pharmazeutische zusammensetzungen.
JO1648B1 (en) Nitrogen compounds

Legal Events

Date Code Title Description
MA Patent expired